You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 3
  • 19 A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study)

Article metrics

Article menu

Download PDFPDF

Plenary sessions
Plenary 3
IGCS19-0619
19 A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 study)
Free

 

Online download statistics by month:

Online download statistics by month: September 2019 to April 2024

AbstractFullPdf
Sep 20191808
Oct 201917013
Nov 20191207
Dec 20191206
Jan 2020700
Feb 20201307
Mar 2020601
Apr 20204204
May 2020203
Jun 20202404
Jul 20202005
Aug 2020402
Sep 2020802
Oct 20201804
Nov 2020602
Dec 2020402
Jan 2021303
Feb 2021003
Mar 20211701
Apr 20211405
May 2021304
Jun 2021103
Jul 2021003
Aug 2021002
Sep 2021003
Oct 20212019
Nov 202114012
Dec 20212001
Jan 20221002
Feb 20222201
Mar 20221601
Apr 2022200
May 20221605
Jun 20221202
Jul 20221000
Aug 20221305
Sep 20221807
Oct 20221904
Nov 2022202
Dec 20222001
Jan 2023401
Feb 2023600
Mar 20231206
Apr 2023803
May 2023801
Jun 2023803
Jul 2023705
Aug 2023602
Sep 20231002
Oct 2023800
Nov 20231203
Dec 20232300
Jan 20243201
Feb 20241001
Mar 202420026
Apr 20241908
Total6400221